| DAA712 |
Heart physiology parameters altered |
Physiological |
heart |
Human |
— |
— |
|
| DAA620 |
Hypertensive heart and renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|
| DAA619 |
Hypertensive heart disease |
Pathological |
heart |
Human |
— |
SeriesMorbidity |
|
| DAA621 |
Ischemic heart disease |
Pathological |
heart |
Human |
— |
SeriesMorbidity |
|
| DAA705 |
Lipofuscin increases |
Physiological |
heart |
Human |
— |
— |
|
| DAA706 |
Maximum workload in response to exercise stress decreases |
Physiological |
heart |
Human |
— |
— |
|
| DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
| DAA1297 |
neural precursor cell expressed, developmentally down-regulated gene 8 |
Molecular |
heart |
Mouse |
Nedd8 |
3.0% Decrease Gene Expression Level |
|
| DAA1292 |
NYN domain and retroviral integrase containing |
Molecular |
heart |
Mouse |
Nynrin |
8.0% Increase Gene Expression Level |
|
| DAA1298 |
opsin 1 (cone pigments), long-wave-sensitive |
Molecular |
heart |
Mouse |
Opn1lw |
19.0% Increase Gene Expression Level |
|
| DAA623 |
Other forms of chronic ischemic heart disease |
Pathological |
heart |
Human |
— |
SeriesMorbidity |
|
| DAA2598 |
Renewal rate of cardiomyocytes decreases with age |
Physiological |
heart |
Human |
— |
— |
|
| DAA708 |
Response to beta-adrenergic stimulation decreased |
Physiological |
heart |
Human |
— |
— |
|
| DAA1296 |
RIKEN cDNA 6720462K09 gene |
Molecular |
heart |
Mouse |
6720462K09Rik |
5.0% Decrease Gene Expression Level |
|
| DAA703 |
Wall increases in thickness |
Physiological |
left ventricle |
Human |
— |
— |
|